ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $429,576 (100.0% shares, 0.0% debt)

Holdings (19)

ACCELERATE DIAGNOSTICS INC 17.0%
Value ($000) $73,208 Shares 5,087,456 Est. Cost $24998.12 Unrealized
NXSTAGE MEDICAL INC 13.5%
Value ($000) $57,897 Shares 2,670,536 Est. Cost $13115.35 Unrealized
TESARO INC 13.0%
Value ($000) $56,058 Shares 666,956 Est. Cost $23880.15 Unrealized
MAZOR ROBOTICS LTD 11.6%
Value ($000) $49,742 Shares 2,766,517 Est. Cost $11234.47 Unrealized
QUIDEL CORP 10.5%
Value ($000) $45,249 Shares 2,533,554 Est. Cost $25530.00 Unrealized
OPK OPKO HEALTH INC 8.5%
Value ($000) $36,557 Shares 3,914,000 Est. Cost $6.96 Unrealized +45.9%
PACB PACIFIC BIOSCIENCES CALIF IN 5.2%
Value ($000) $22,387 Shares 3,182,269 Est. Cost $4.10 Unrealized +122.7%
ARAY ACCURAY INC 3.0%
Value ($000) $12,885 Shares 2,482,718 Est. Cost $5.71 Unrealized -4.2%
BIOLASE INC 2.9%
Value ($000) $12,320 Shares 10,529,525 Est. Cost $1522.78 Unrealized
AMARIN CORP PLC 2.9%
Value ($000) $12,294 Shares 5,691,572 Est. Cost $947.16 Unrealized
HANSEN MEDICAL 2.7%
Value ($000) $11,702 Shares 4,491,820 Est. Cost $722.69 Unrealized
INTREXON CORP 2.6%
Value ($000) $11,309 Shares 459,529 Est. Cost $7613.52 Unrealized
VERMILLION INC 2.2%
Value ($000) $9,573 Shares 8,624,225 Est. Cost $1646.88 Unrealized
AGENUS INC 1.8%
Value ($000) $7,523 Shares 1,857,477 Est. Cost $1053.96 Unrealized
TRANSITION THERAPEUTICS INC 1.3%
Value ($000) $5,612 Shares 3,817,972 Est. Cost $3769.73 Unrealized
CONTRAFECT CORP 0.8%
Value ($000) $3,416 Shares 1,182,032 Est. Cost $5.25 Unrealized
BIIB BIOGEN INC 0.4%
Value ($000) $1,625 Shares 6,723 Est. Cost $213.68 Unrealized +23.3%
SECOND SIGHT MED PRODS INC 0.0%
Value ($000) $182 Shares 50,804 Est. Cost $10.26 Unrealized
ZIOPHARM ONCOLOGY INC 0.0%
Value ($000) $37 Shares 6,661 Est. Cost $12.00 Unrealized